NKTR
Nektar Therapeutics
Price:  
0.90 
USD
Volume:  
22,344,688.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR WACC - Weighted Average Cost of Capital

The WACC of Nektar Therapeutics (NKTR) is 8.4%.

The Cost of Equity of Nektar Therapeutics (NKTR) is 11.90%.
The Cost of Debt of Nektar Therapeutics (NKTR) is 5.00%.

Range Selected
Cost of equity 9.20% - 14.60% 11.90%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.1% - 9.8% 8.4%
WACC

NKTR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.17 1.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.20% 14.60%
Tax rate 0.10% 0.20%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.1% 9.8%
Selected WACC 8.4%